Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thioguanine in inflammatory bowel disease: Long-term efficacy and safety.
Ward MG, Patel KV, Kariyawasam VC, Goel R, Warner B, Elliott TR, Blaker PA, Irving PM, Marinaki AM, Sanderson JD. Ward MG, et al. Among authors: kariyawasam vc. United European Gastroenterol J. 2017 Jun;5(4):563-570. doi: 10.1177/2050640616663438. Epub 2016 Aug 1. United European Gastroenterol J. 2017. PMID: 28588888 Free PMC article.
Determining efficacy of dynamic multimedia bowel preparation instructions versus standard instructions on adenoma detection and patient reported measures (DIGICLEAN trial): a study protocol for a multicentre, colonoscopist-blinded, randomised controlled trial.
Au M, Low P, Rennie M, Mohseni M, Song Y, Kim N, Baraty B, Mitrev N, He E, Ho V, Leong R, Kariyawasam V. Au M, et al. BMJ Open. 2023 Jul 21;13(7):e073843. doi: 10.1136/bmjopen-2023-073843. BMJ Open. 2023. PMID: 37479508 Free PMC article.
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease.
Kariyawasam VC, Ward MG, Blaker PA, Patel KV, Goel R, Sanderson JD, Irving PM. Kariyawasam VC, et al. Inflamm Bowel Dis. 2017 Sep;23(9):1555-1565. doi: 10.1097/MIB.0000000000001183. Inflamm Bowel Dis. 2017. PMID: 28786865
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial.
Pudipeddi A, Paramsothy S, Kariyawasam V, Paramsothy R, Ghaly S, Haifer C, An YK, Begun J, Connor SJ, Corte C, Ward MG, De Cruz P, Lan-San Fung C, Redmond D, Chan W, Mourad F, Kermeen M, Leong RW. Pudipeddi A, et al. Clin Gastroenterol Hepatol. 2024 Nov;22(11):2299-2308.e5. doi: 10.1016/j.cgh.2024.04.019. Epub 2024 May 9. Clin Gastroenterol Hepatol. 2024. PMID: 38729400 Free article. Clinical Trial.
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Mitrev N, et al. Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. doi: 10.1111/apt.14368. Epub 2017 Oct 13. Aliment Pharmacol Ther. 2017. PMID: 29027257 Review.
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey.
Chan W, Kariyawasam VC, Kim S, Pudipeddi AV, Paramsothy S, Shim HH, Mourad FH, Ding N, Ferrante M, Leong RW. Chan W, et al. Among authors: kariyawasam vc. Eur J Gastroenterol Hepatol. 2020 Aug;32(8):976-983. doi: 10.1097/MEG.0000000000001768. Eur J Gastroenterol Hepatol. 2020. PMID: 32453008
43 results